Minerva Neurosciences, Inc. share price logo

Minerva Neurosciences, Inc. Share Price

NASDAQ: NERV

Small Cap

$5.19

-0.04

(-0.76%)

as on

Minerva Neurosciences, Inc. Stock Performance

as on April 8, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.13
    $5.34
    downward going graph

    1.16%

    Downside

    2.89%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.15
    $12.46
    downward going graph

    77.84%

    Downside

    140.08%

    Upside

    downward going graph

Minerva Neurosciences, Inc. share price movements today

Previous Close
$5.23
Open
$5.33
Volume
779.0K
Day's Low - High
$5.13 - $5.34
52 Week Low - High
$1.15 - $12.46

Minerva Neurosciences, Inc. Historical Returns

1 Month Return
-12.98 %
3 Month Return
+ 11.04 %
1 Year Return
+ 273.57 %
3 Year Return
+ 220.86 %
5 Year Return
-75.24 %

Minerva Neurosciences, Inc. Stock Fundamentals & Key Indicators

Check Minerva Neurosciences, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$228.5M

EPS (TTM)

-0.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-15.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-675.09%

Minerva Neurosciences, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Minerva Neurosciences, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Minerva Neurosciences, Inc. image
Minerva Neurosciences, Inc.
SELL$228.5M-75.24%NA0.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B134.83%136.858.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B104.17%28.6632.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA126.855.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B58.38%18.3831.41%

Stock Returns calculator for Minerva Neurosciences, Inc. Stock including INR - Dollar returns

The Minerva Neurosciences, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Minerva Neurosciences, Inc. investment value today

Current value as on today

₹4,01,474

Returns

₹3,01,474

(+301.47%)

Returns from Minerva Neurosciences, Inc. Stock

₹2,70,714 (+270.71%)

Dollar Impact

₹30,760 (+30.76%)

Analyst Recommendation on Minerva Neurosciences, Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Minerva Neurosciences, Inc.. Average target price of $7.25

Minerva Neurosciences, Inc. Share Price Target

Get share price movements and forecasts by analysts on Minerva Neurosciences, Inc..

What analysts predicted

28.41%UPSIDE

Target Price

$7.25

Current Price

$5.19

Analyzed by

6 Analysts

Target

$7.25

Minerva Neurosciences, Inc. target price $7.25, a slight upside of 28.41% compared to current price of $5.19. According to 6 analysts rating.

Minerva Neurosciences, Inc. Stock’s Investor Sentiment and Interest

Search interest for Minerva Neurosciences, Inc. Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:3% versus previous 30 day period

Minerva Neurosciences, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
0
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-6
-7
-6
-6
-4
-4
-3
-3
-2
-4
EBITDA
-5
-6
-6
-5
22
-4
-4
-3
-2
-4
Interest Expense
2
2
2
2
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-7
-9
-8
-8
22
-4
-3
-3
-2
-283
Income Tax Expense
0
-5
0
0
0
-
-
-
-
-
Net Income
-7
-9
-8
-8
22
-4
-3
-3
-2
-283
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-10119.02%
-8889.51%
0.00%
0.00%
0.00%

Minerva Neurosciences, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
41
41
-
-
-
-
-
Gross Profit
0
0
0
0
41
0
0
0
0
0
Operating Income
-30
-41
-51
-75
1
-45
-25
-23
-21
-15
EBITDA
-29
-40
-50
-74
2
-45
-24
-21
6
-15
Interest Expense
1
0
0
1
-
6
7
8
4
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-31
-40
-50
-74
1
-51
-32
-30
1
-293
Income Tax Expense
1
-9
1
-2
0
-1
6
0
-
-
Net Income
-31
-31
-50
-72
1
-49
-32
-30
1
-293
Net Profit Margin
0.00%
0.00%
0.00%
-175.31%
4.71%
0.00%
0.00%
0.00%
0.00%
0.00%

Minerva Neurosciences, Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-9
-8
-8
22
-4
-4
-3
-2
-283
Operating Cash Flow
-5
-6
-3
-4
-5
-5
-2
-2
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
-
Financing Cash Flow
19,584
-
-
-
-
-
-
0
74
Change in Cash
-5
-6
-3
-4
-5
-5
-2
-2
70

Minerva Neurosciences, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-31
-50
-72
1
-49
-32
-30
1
-293
Operating Cash Flow
3
-41
-43
-33
-24
-24
-14
-19
-13,510
Investing Cash Flow
-107
69
14
24
0
0
-
-
-
Financing Cash Flow
47
-3
0
13
60
0
19
-
74,450
Change in Cash
-56
24
-28
3
35
-24
4
-19
60,939

Global Institutional Holdings in Minerva Neurosciences, Inc.

Funds
Holdings
Deutsche Bank AG
0%
JONES FINANCIAL COMPANIES LLLP
0%
Adage Capital Partners Gp LLC
6.56%
Farallon Capital Management, L.L.C.
5.47%
SBI Securities Co Ltd
0%
See all

Minerva Neurosciences, Inc. News & Key Events

  • img

    Today's Timeline - 21 October

    Tue, 06:40 PM

    -

    Minerva Neurosciences announces $200 million funding for roluperidone development, including $80 million upfront for Phase 3 trial.

Insights on Minerva Neurosciences, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, NERV has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NERV has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NERV stock has moved down by -13.2%

About Minerva Neurosciences, Inc.

minerva neurosciences, inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of a portfolio of product candidates for the treatment of central nervous system diseases. its lead product candidate is roluperidone, which is in phase iii clinical trial, a compound for the treatment of schizophrenia. the company is also developing seltorexant that has completed phase iib clinical trial for treating insomnia and major depressive disorders; and min-301, which is in pre-clinical trial, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of parkinson's disease. minerva neurosciences, inc. has a license agreement with mitsubishi tanabe pharma corporation for the development and commercialization of the roluperidone worldwide, excluding asia; and co-development and license agreement with janssen pharmaceutica, n.v. for the development of seltorexant. the company was formerly known as cyrenaic pharmaceuticals, inc. and changed its
OrganisationMinerva Neurosciences, Inc.
Headquarters1500 District Avenue, Burlington, MA, United States, 01803
IndustryHealth Technology
CEODr. Remy Luthringer Ph.D.
E-voting on sharesClick here to vote

Key Management of Minerva Neurosciences, Inc.

Name

Title

Mr. William B. Boni

Vice President of Investor Relations & Corporate Communications

Prof. Michael Davidson M.D.

Chief Medical Officer

Dr. Remy Luthringer Ph.D.

Executive Chairman & CEO

Mr. Geoffrey Robin Race F.C.M.A., M.B.A.

President

Mr. Frederick W. Ahlholm CPA

Senior VP, CFO & Secretary

Mr. Joseph Reilly

Senior VP & COO

FAQs

What is Minerva Neurosciences, Inc. share price today?

Minerva Neurosciences, Inc. share price today is $5.19 as on at the close of the market. Minerva Neurosciences, Inc. share today touched a day high of $5.34 and a low of $5.13.

What is the 52 week high and 52 week low for Minerva Neurosciences, Inc. share?

Minerva Neurosciences, Inc. share touched a 52 week high of $12.46 on and a 52 week low of $1.15 on . Minerva Neurosciences, Inc. stock price today i.e. is closed at $5.19,which is 58.35% down from its 52 week high and 351.30% up from its 52 week low.

What is Minerva Neurosciences, Inc.'s market capitalisation today?

Minerva Neurosciences, Inc. market capitalisation is $0.00T as on .

How to invest in Minerva Neurosciences, Inc. Stock (NERV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Minerva Neurosciences, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Minerva Neurosciences, Inc. Shares that will get you 0.2890 shares as per Minerva Neurosciences, Inc. share price of $5.19 per share as on April 8, 2026 at 1:29 am IST.

What is the minimum amount required to buy Minerva Neurosciences, Inc. Stock (NERV) from India?

Indian investors can start investing in Minerva Neurosciences, Inc. (NERV) shares with as little as ₹93.0075 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.07 in Minerva Neurosciences, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Minerva Neurosciences, Inc. share’s latest price of $5.19 as on April 8, 2026 at 1:29 am IST, you will get 1.9268 shares of Minerva Neurosciences, Inc.. Learn more about fractional shares .

What are the returns that Minerva Neurosciences, Inc. has given to Indian investors in the last 5 years?

Minerva Neurosciences, Inc. stock has given -75.24% share price returns and 25.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?